Who are we? What do we do?

Metavone is a drug discovery and development company focused on the development of therapeutic treatments for dementia and hormone related cancers. It has intellectual property rights to two patents covering its Isoflavone Drug Technology featuring a significant number of isoflavone compounds.

Pre-clinical testing of a number of these isoflavone compounds by a combination of computer based modelling, laboratory testing and, in one case, animal (mouse) trials have demonstrated the potential to develop some of the compounds as therapeutic treatment of neurological conditions such as dementia and for hormone dependent cancers such as breast, prostate and ovarian cancers.

The dementia and hormone related cancer markets are globally significant and have featured large growth. The Company’s business model enables it to diversify the potential risks associated with solely targeting one disorder.